BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26511472)

  • 1. Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications.
    Tayebati SK; Marucci G; Santinelli C; Buccioni M; Amenta F
    Curr Med Chem; 2015; 22(38):4328-40. PubMed ID: 26511472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline-containing phospholipids: relevance to brain functional pathways.
    Tayebati SK; Amenta F
    Clin Chem Lab Med; 2013 Mar; 51(3):513-21. PubMed ID: 23314552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of choline containing phospholipids on the neurovascular unit: A review.
    Roy P; Tomassoni D; Nittari G; Traini E; Amenta F
    Front Cell Neurosci; 2022; 16():988759. PubMed ID: 36212684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of monoaminergic transporters by choline-containing phospholipids in rat brain.
    Tayebati SK; Tomassoni D; Nwankwo IE; Di Stefano A; Sozio P; Cerasa LS; Amenta F
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):94-103. PubMed ID: 23244432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
    Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
    J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of choline-containing phospholipids on brain cholinergic transporters in the rat.
    Tayebati SK; Tomassoni D; Di Stefano A; Sozio P; Cerasa LS; Amenta F
    J Neurol Sci; 2011 Mar; 302(1-2):49-57. PubMed ID: 21195433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choline alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline- containing phospholipid with a still interesting profile as cognition enhancing agent.
    Traini E; Bramanti V; Amenta F
    Curr Alzheimer Res; 2013 Dec; 10(10):1070-9. PubMed ID: 24156263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain.
    Tayebati SK; Martinelli I; Moruzzi M; Amenta F; Tomassoni D
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28961195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid and Lipid Derivatives as Potential Neuroprotective Compounds.
    Tayebati SK
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30189584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.
    Parnetti L; Amenta F; Gallai V
    Mech Ageing Dev; 2001 Nov; 122(16):2041-55. PubMed ID: 11589921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly pure phospholipids based brain docosahexaenoic acid transporters.
    Chen S
    Recent Pat CNS Drug Discov; 2010 Jun; 5(2):135-46. PubMed ID: 19832689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids.
    Klein J
    J Neural Transm (Vienna); 2000; 107(8-9):1027-63. PubMed ID: 11041281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citicoline: pharmacological and clinical review, 2006 update.
    Secades JJ; Lorenzo JL
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phospholipids metabolism disorders in acute stroke].
    Solovieva EY; Farrahova KI; Karneev AN; Chipova DT
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(1):104-112. PubMed ID: 27045147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities.
    Javaid S; Farooq T; Rehman Z; Afzal A; Ashraf W; Rasool MF; Alqahtani F; Alsanea S; Alasmari F; Alanazi MM; Alharbi M; Imran I
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration.
    Janssen CI; Kiliaan AJ
    Prog Lipid Res; 2014 Jan; 53():1-17. PubMed ID: 24334113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the turnover of endogenous choline-containing phospholipids of cultured neuroblastoma cells.
    D'Souza CJ; Clarke JT; Cook HW; Spence MW
    Biochim Biophys Acta; 1983 Aug; 752(3):467-73. PubMed ID: 6871241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of the 'organic osmolyte' glycerophosphorylcholine in isolated rat inner medullary collecting duct cells. I. Pathways for synthesis and degradation.
    Bauernschmitt HG; Kinne RK
    Biochim Biophys Acta; 1993 Jun; 1148(2):331-41. PubMed ID: 8504126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.